The Cannabis Buyers' Clubs of Canada, Victoria BC, has been providing cannabis products to people with permanent physical disabilities or diseases since 1996
By Dr. Lester Grinspoon, M.D.
Like everyone else who has been working over decades to ensure that marijuana, with all that it has to offer, is allowed to take its proper place in our lives, I have been heartened by the rapidly growing pace at which it is gaining understanding as a safe and versatile medicine.
In addition to the relief it offers to so many patients with a large array of symptoms and syndromes (almost invariably at less cost, both in toxicity and money than the conventional drugs it replaces), it is providing those patients, their caregivers, and the people who are close to them an opportunity to see for themselves how useful and unthreatening its use is. Read the rest of this entry »
What seems to be misunderstood by the Member of Parliament is that Clause 39 – 41 of Bill C-10, in effect, amounts to the providing of insulation for organized crime and drug kingpins. This consequence would, for the most part, be triggered by the enactment of the proposed changes to the medical marihuana program by Health Canada.
Some British patients are now traveling to the Netherlands for their cannabis medicine, where medical use is legal. Countries such as Germany and Denmark purchase Sativex, made by GW Pharmaceuticals, as pain and spasm relieving medicine. Sativex is a cannabis tincture that should be made more accessible to those in need.
Sarah is now the British representative for the the International Association of Cannabinoid Medicines (IACM) and recently delivered a presentation at a convention in Bonn, Germany. Her interest lies in ‘whole plant’ cannabis research and medical use.
Americans for Safe Access also has links to research studies suggesting that cannabis may help in the treatment or prevention of Alzheimer’s disease and cancer, while the International Association for Cannabis as Medicine highlights the following medical uses
Alzheimer’s disease is the leading cause of dementia among the elderly, and with the ever-increasing size of this population, cases of Alzheimer’s disease are expected to triple over the next 50 years.
